News/Media
Our Latest Updates & News
Lectenz Bio Signs Distribution Agreement with Apical Lab Corp.
Lectenz Bio has recently signed a distribution agreement with Apical Lab Corp., a Taiwanese life science distributor. This agreement will...
Lectenz Bio receives NIH NIGMS SBIR Phase II
The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to...
Lectenz Bio receives NIH SBIR Fast-Track
The National Institute of Health (NIH) Office of Research Infrastructure Programs (ORIP) awards Lectenz Bio an SBIR Fast-Track to develop...
Lectenz Bio Signs Distribution Agreement with ZAGENO
Lectenz Bio has recently signed a distribution agreement with ZAGENO, a European life science distributor. This agreement will allow...
Lectenz Bio Products Are Now Listed With Cedarlane
Cedarlane is now distributing Lectenz Bio products for Canadian customers. We are excited to have Cedarlane listing our catalog and look...
Lectenz Bio Signs Distribution Agreement with MBL Beijing Biotech Co., Ltd.
Lectenz Bio has recently signed a distribution agreement with MBL Beijing Biotech Co., Ltd., a Chinese life science distributor. This...
Lectenz Bio Signs Distribution Agreement with Scientist.com
Lectenz Bio has recently signed a distribution agreement with Scientist.com, a U.S. life science distributor. This agreement will allow...
Lectenz Bio at 2022 Common Fund GlycoScience Program
Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program!
Lectenz Bio at 2022 Rare Disease Day Symposium
Lectenz Bio was proud to be a sponsor of the 2022 Rare Disease Day Symposium & CDG/NGLY1 Family Conference! It's always exciting to...
Browse our products